📊 FCRX Key Takeaways
Is Crescent Capital BDC, Inc. (FCRX) a Good Investment?
Crescent Capital BDC faces significant operational challenges with negative operating income of -98.7M and severely strained leverage at 1.24x debt-to-equity, indicating the company is not generating sufficient returns to cover its debt obligations. While positive net income of 34.5M and operating cash flow of 74.7M suggest some value realization from investments, these are offset by deteriorating profitability (net income down 53.1% YoY) and a negative interest coverage ratio of -1.7x, signaling potential distress in servicing debt.
Crescent Capital BDC shows weakening profitability, with net income down 53.1% year over year and diluted EPS down 24.6%, while reported operating income is deeply negative. Although operating cash flow remains positive and equity still supports the balance sheet, leverage is meaningful and weak interest coverage suggests limited cushion if earnings remain under pressure.
Why Buy Crescent Capital BDC, Inc. Stock? FCRX Key Strengths
- Positive operating cash flow of 74.7M demonstrates ability to generate cash from core operations
- Net income of 34.5M indicates some investment gains and distributions despite operational losses
- Total asset base of 1.6B provides diversified investment portfolio typical of BDCs
- Positive operating cash flow of $74.72M indicates the portfolio is still generating cash
- Equity base of $706.04M provides balance sheet support
- ROE and ROA remain positive, showing the company is still profitable on a net basis
FCRX Stock Risks: Crescent Capital BDC, Inc. Investment Risks
- Negative operating income of -98.7M and negative interest coverage ratio (-1.7x) indicate inability to cover debt service from operations
- High leverage at 1.24x debt-to-equity with 873.8M long-term debt relative to 706.0M equity poses refinancing and solvency risks
- Sharp 53.1% year-over-year decline in net income and 24.6% EPS decline suggests deteriorating investment performance and asset quality
- Minimal cash position of 5.0M relative to 873.8M debt creates liquidity vulnerability
- Zero insider buying activity in last 90 days suggests lack of confidence from management
- Net income and EPS declined sharply year over year, signaling deteriorating earnings quality
- High leverage with $873.76M of long-term debt and 1.24x debt-to-equity increases balance sheet risk
- Negative operating income and -1.7x interest coverage indicate weak earnings support for debt obligations
Key Metrics to Watch
- Operating income trend and return on portfolio assets
- Debt service coverage ratio and interest coverage improvement
- Net income sustainability and investment realization trends
- Debt-to-equity ratio movement and refinancing requirements
- Cash flow generation relative to distributions and debt obligations
- Net investment income and net income trend
- Debt-to-equity and interest coverage
Crescent Capital BDC, Inc. (FCRX) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
FCRX Profit Margin, ROE & Profitability Analysis
FCRX vs Market Sector: How Crescent Capital BDC, Inc. Compares
How Crescent Capital BDC, Inc. compares to Market sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Crescent Capital BDC, Inc. Stock Overvalued? FCRX Valuation Analysis 2026
Based on fundamental analysis, Crescent Capital BDC, Inc. shows some fundamental concerns relative to the Market sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Crescent Capital BDC, Inc. Balance Sheet: FCRX Debt, Cash & Liquidity
FCRX Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Crescent Capital BDC, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $2.30 reflects profitable operations.
FCRX Revenue Growth, EPS Growth & YoY Performance
Crescent Capital BDC, Inc. Dividends, Buybacks & Capital Allocation
FCRX SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Crescent Capital BDC, Inc. (CIK: 0001633336)
📋 Recent SEC Filings
❓ Frequently Asked Questions about FCRX
What is the AI rating for FCRX?
Crescent Capital BDC, Inc. (FCRX) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (SELL) with 77% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are FCRX's key strengths?
Claude: Positive operating cash flow of 74.7M demonstrates ability to generate cash from core operations. Net income of 34.5M indicates some investment gains and distributions despite operational losses. ChatGPT: Positive operating cash flow of $74.72M indicates the portfolio is still generating cash. Equity base of $706.04M provides balance sheet support.
What are the risks of investing in FCRX?
Claude: Negative operating income of -98.7M and negative interest coverage ratio (-1.7x) indicate inability to cover debt service from operations. High leverage at 1.24x debt-to-equity with 873.8M long-term debt relative to 706.0M equity poses refinancing and solvency risks. ChatGPT: Net income and EPS declined sharply year over year, signaling deteriorating earnings quality. High leverage with $873.76M of long-term debt and 1.24x debt-to-equity increases balance sheet risk.
What is FCRX's revenue and growth?
Crescent Capital BDC, Inc. reported revenue of N/A.
Does FCRX pay dividends?
Crescent Capital BDC, Inc. pays dividends, with $67.8M distributed to shareholders in the trailing twelve months.
Where can I find FCRX SEC filings?
Official SEC filings for Crescent Capital BDC, Inc. (CIK: 0001633336) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is FCRX's EPS?
Crescent Capital BDC, Inc. has a diluted EPS of $1.81.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is FCRX a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Crescent Capital BDC, Inc. has a SELL rating with 77% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is FCRX stock overvalued or undervalued?
Valuation metrics for FCRX: ROE of 4.9% (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy FCRX stock in 2026?
Our dual AI analysis gives Crescent Capital BDC, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is FCRX's free cash flow?
Crescent Capital BDC, Inc.'s operating cash flow is $74.7M, with capital expenditures of N/A.
How does FCRX compare to other Market stocks?
Vs Default sector averages: Net margin N/A (avg: 12%), ROE 4.9% (avg: 15%), current ratio N/A (avg: 1.8).